arrow
C

Cathia Soulié

institut national de la santé et de la recherche médicale (inserm)
H指数:31
被引数:3,419

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of switching to once-daily oral doravirine plus raltegravir in virologically suppressed people with HIV-1: a randomized, open-label, multicentre phase 2 study (DORAL)

HIV-1病毒学抑制患者转换为每日一次口服多拉韦林联合拉替拉韦的疗效与安全性:一项随机、开放标签、多中心Ⅱ期研究(DORAL)

2026-10-070
PRE
Clearance of NNRTI resistance-associated mutations in the HIV-1 DNA reservoir with or without the presence of M184V mutation

HIV-1 DNA储库中NNRTI耐药相关突变的清除:有无M184V突变存在的情况

2026-07-150
PRE
Viral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort study
2025-12-010
OAAI
Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable

尽管整合酶抑制剂在治疗HIV感染中的使用日益增多,但对该类药物的耐药性仍然稳定。

2025-12-010
PRE
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study

从依曲韦林转换为多拉韦林在病毒学抑制的HIV感染者中的疗效:法国多中心SWEED观察性研究的结果

2025-11-010
PRE
Uptake of drug-reduced antiretroviral strategies and impact on costs over 2015-22: experience from an HIV clinic in Paris, France

2015-2022年抗逆转录病毒药物减量策略的采用及其对成本的影响:来自法国巴黎一家HIV诊所的经验

2025-08-010
PRE
SARS-CoV-2 lineage-dependent temporal phylogenetic distribution and viral load in immunocompromised and immunocompetent individuals

SARS-CoV-2谱系依赖性的时间系统发育分布及免疫缺陷与免疫健全个体的病毒载量

2025-04-250
OA
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs
2024-12-200
PRE
Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study

双重单克隆抗体治疗新型冠状病毒肺炎进化的比较: 多中心回顾性研究

2024-09-290
OAAI
DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine
2024-06-170
PRE
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART
2024-02-201
OAAI
Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies

单克隆抗体治疗的严重冠状病毒疾病2019高危患者的刺突蛋白遗传进化

2023-11-235
OA
Higher Levels of SARS-CoV-2 Genetic Variation in Immunocompromised Patients: A Retrospective Case-Control Study
2023-11-133
OA
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients
MED
IF11.8
2023-10-018
OAAI